In vitro and in vivo genotoxicity investigations of differently sized amorphous SiO2 nanomaterials.

[1]  Reinhard Kreiling,et al.  A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). , 2015, Regulatory toxicology and pharmacology : RTP.

[2]  Henriqueta Louro,et al.  Genotoxicity of synthetic amorphous silica nanoparticles in rats following short‐term exposure. Part 1: Oral route , 2015, Environmental and molecular mutagenesis.

[3]  V. Fessard,et al.  Genotoxicity of synthetic amorphous silica nanoparticles in rats following short‐term exposure, part 2: Intratracheal instillation and intravenous injection , 2015, Environmental and molecular mutagenesis.

[4]  Robert Landsiedel,et al.  Influence of dispersive agent on nanomaterial agglomeration and implications for biological effects in vivo or in vitro. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  Jürgen Schnekenburger,et al.  Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. , 2014, Nanomedicine.

[6]  Robert Landsiedel,et al.  Concern-Driven Safety Assessment of Nanomaterials: An Integrated Approach Using Material Properties, Hazard, Biokinetic, and Exposure Data and Considerations on Grouping and Read-Across , 2014 .

[7]  M. Voetz,et al.  As-Produced: Intrinsic Physico-Chemical Properties and Appropriate Characterization Tools , 2014 .

[8]  F. Alessandrini,et al.  Toxicological effects of metal oxide nanomaterials , 2014 .

[9]  M. Kirsch‐Volders,et al.  Co-assessment of cell cycle and micronucleus frequencies demonstrates the influence of serum on the in vitro genotoxic response to amorphous monodisperse silica nanoparticles of varying sizes , 2014, Nanotoxicology.

[10]  N. Konduru,et al.  Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium , 2014 .

[11]  Reinhard Kreiling,et al.  A critical appraisal of existing concepts for the grouping of nanomaterials. , 2014, Regulatory toxicology and pharmacology : RTP.

[12]  C. Scoglio,et al.  Nanoparticle surface characterization and clustering through concentration-dependent surface adsorption modeling. , 2014, ACS nano.

[13]  Maria Dusinska,et al.  Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles , 2014, Nanotoxicology.

[14]  M. Wiemann,et al.  Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials , 2014, Particle and Fibre Toxicology.

[15]  Robert Landsiedel,et al.  Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. , 2014, Toxicology and applied pharmacology.

[16]  Philip Demokritou,et al.  Estimating the effective density of engineered nanomaterials for in vitro dosimetry , 2014, Nature Communications.

[17]  Barbara Witt,et al.  Cytotoxicity and genotoxicity of nano - and microparticulate copper oxide: role of solubility and intracellular bioavailability , 2014, Particle and Fibre Toxicology.

[18]  P. Magusin,et al.  Nucleation and growth of monodisperse silica nanoparticles. , 2014, Nano letters.

[19]  Maria João Silva,et al.  Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  A. Elder,et al.  Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation , 2014, Particle and Fibre Toxicology.

[21]  Craig A. Poland,et al.  Nanotoxicity: challenging the myth of nano-specific toxicity. , 2013, Current opinion in biotechnology.

[22]  D. Lison,et al.  In search of the chemical basis of the hemolytic potential of silicas. , 2013, Chemical research in toxicology.

[23]  Hugh J. Byrne,et al.  Concern-driven integrated approaches to nanomaterial testing and assessment – report of the NanoSafety Cluster Working Group 10 , 2013, Nanotoxicology.

[24]  Robert Landsiedel,et al.  Genotoxicity of nanomaterials: Refining strategies and tests for hazard identification , 2013, Environmental and molecular mutagenesis.

[25]  B. Onida,et al.  Genotoxicity of amorphous silica particles with different structure and dimension in human and murine cell lines. , 2013, Mutagenesis.

[26]  Dong‐Wan Kim,et al.  Comparison of toxicity between the different-type TiO2 nanowires in vivo and in vitro , 2013, Archives of Toxicology.

[27]  Heinrich Ernst,et al.  Evaluation of immunohistochemical markers to detect the genotoxic mode of action of fine and ultrafine dusts in rat lungs. , 2013, Toxicology.

[28]  P. Morfeld,et al.  Deposition behavior of inhaled nanostructured TiO2 in rats: fractions of particle diameter below 100 nm (nanoscale) and the slicing bias of transmission electron microscopy , 2012, Inhalation toxicology.

[29]  Wendel Wohlleben,et al.  Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas , 2012, Journal of Nanoparticle Research.

[30]  K. Turteltaub,et al.  Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry. , 2012, Nano letters.

[31]  Y. Yoshioka,et al.  Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells. , 2012, Biochemical and biophysical research communications.

[32]  M. Morille,et al.  Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. , 2012, Toxicology.

[33]  N. Hondow,et al.  Mechanism of cellular uptake of genotoxic silica nanoparticles , 2012, Particle and Fibre Toxicology.

[34]  A. T. Saber,et al.  Inflammatory and genotoxic effects of nanoparticles designed for inclusion in paints and lacquers , 2012, Nanotoxicology.

[35]  G. Giudetti,et al.  Mechanisms of toxicity induced by SiO2 nanoparticles of in vitro human alveolar barrier: effects on cytokine production, oxidative stress induction, surfactant proteins A mRNA expression and nanoparticles uptake , 2012, Nanotoxicology.

[36]  H. Karlsson,et al.  DNA damage induced by micro- and nanoparticles--interaction with FPG influences the detection of DNA oxidation in the comet assay. , 2012, Mutagenesis.

[37]  Maria Dusinska,et al.  Can Standard Genotoxicity Tests be Applied to Nanoparticles? , 2012, Journal of toxicology and environmental health. Part A.

[38]  Robert Landsiedel,et al.  Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[39]  Douglas Gilliland,et al.  Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts. , 2012, Mutation research.

[40]  Stefan Pfuhler,et al.  Silica nanoparticles administered at the maximum tolerated dose induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. , 2012, Mutation research.

[41]  B. van Ravenzwaay,et al.  Investigation on the genotoxicity of different sizes of gold nanoparticles administered to the lungs of rats. , 2012, Mutation research.

[42]  Benoit Nemery,et al.  Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: the role of size and surface area. , 2012, Toxicology letters.

[43]  J. Godnić-Cvar,et al.  Genotoxicity of Metal Nanoparticles: Focus on In Vivo Studies , 2012, Arhiv za higijenu rada i toksikologiju.

[44]  Claus-Michael Lehr,et al.  Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions. , 2012, ACS nano.

[45]  F. Oesch,et al.  Toxico-/biokinetics of nanomaterials , 2012, Archives of Toxicology.

[46]  H. Bockhorn,et al.  Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages , 2012, Nanotoxicology.

[47]  C. Klein,et al.  Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies , 2012, Archives of Toxicology.

[48]  Claudia Fruijtier-Pölloth.  The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material. , 2012, Toxicology.

[49]  S. Słomkowski,et al.  Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro , 2012, Nanotoxicology.

[50]  Sumit Arora,et al.  Nanotoxicology and in vitro studies: the need of the hour. , 2012, Toxicology and applied pharmacology.

[51]  W. Wohlleben,et al.  Artifacts by marker enzyme adsorption on nanomaterials in cytotoxicity assays with tissue cultures , 2011 .

[52]  Wim H de Jong,et al.  Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay , 2011, Nanotoxicology.

[53]  M. Roller,et al.  In vitro genotoxicity data of nanomaterials compared to carcinogenic potency of inorganic substances after inhalational exposure. , 2011, Mutation research.

[54]  Dominique Lison,et al.  The nanosilica hazard: another variable entity , 2010, Particle and Fibre Toxicology.

[55]  Joel G Pounds,et al.  ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.

[56]  M. Kirsch‐Volders,et al.  Exploring the aneugenic and clastogenic potential in the nanosize range: A549 human lung carcinoma cells and amorphous monodisperse silica nanoparticles as models , 2010, Nanotoxicology.

[57]  David B Warheit,et al.  Rationale of genotoxicity testing of nanomaterials: Regulatory requirements and appropriateness of available OECD test guidelines , 2010, Nanotoxicology.

[58]  F. Oesch,et al.  Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UV-protection in cosmetic formulations , 2010, Nanotoxicology.

[59]  Mark Bradley,et al.  Metal Oxide Nanoparticles Induce Unique Inflammatory Footprints in the Lung: Important Implications for Nanoparticle Testing , 2010, Environmental health perspectives.

[60]  L. Ferguson.  Chronic inflammation and mutagenesis. , 2010, Mutation research.

[61]  David B Warheit,et al.  Changing the dose metric for inhalation toxicity studies: Short-term study in rats with engineered aerosolized amorphous silica nanoparticles , 2010, Inhalation toxicology.

[62]  Marianne Geiser,et al.  Deposition and biokinetics of inhaled nanoparticles , 2010, Particle and Fibre Toxicology.

[63]  Amy K Madl,et al.  Health effects of inhaled engineered and incidental nanoparticles , 2009, Critical reviews in toxicology.

[64]  Saji George,et al.  A predictive toxicological paradigm for the safety assessment of nanomaterials. , 2009, ACS nano.

[65]  H. Karlsson,et al.  Size-dependent toxicity of metal oxide particles--a comparison between nano- and micrometer size. , 2009, Toxicology letters.

[66]  Laetitia Gonzalez,et al.  Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. , 2009, Small.

[67]  Markus Schulz,et al.  Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. , 2009, Mutation research.

[68]  Chao Liu,et al.  Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition , 2009, Journal of applied toxicology : JAT.

[69]  Iseult Lynch,et al.  Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. , 2008, Nano letters.

[70]  Takashi Omori,et al.  Statistical issues in the use of the comet assay. , 2008, Mutagenesis.

[71]  Laetitia Gonzalez,et al.  Genotoxicity of engineered nanomaterials: A critical review , 2008 .

[72]  J. Arts,et al.  Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[73]  Joel G Pounds,et al.  Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[74]  Roel P F Schins,et al.  Genotoxicity of Poorly Soluble Particles , 2007, Inhalation toxicology.

[75]  Vicki Stone,et al.  Toxicology of nanoparticles: A historical perspective , 2007 .

[76]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[77]  W. MacNee,et al.  Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure , 2005, Particle and Fibre Toxicology.

[78]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[79]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[80]  Dieter Hauschke,et al.  Biostatistical Assessment of Mutagenicity Studies by Including the Positive Control , 2005, Biometrical journal. Biometrische Zeitschrift.

[81]  David M. Brown,et al.  Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[82]  Ludwig A Hothorn,et al.  Two-stage Testing of Safety: A Statistical View , 2003, Alternatives to laboratory animals : ATLA.

[83]  M. O’Reilly,et al.  Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[84]  B. Brunekreef,et al.  IMMUNE BIOMARKERS IN RELATION TO EXPOSURE TO PARTICULATE MATTER: A Cross-Sectional Survey in 17 Cities of Central Europe , 2000, Inhalation toxicology.

[85]  Stephen S. Olin,et al.  THE RELEVANCE OF THE RAT LUNG RESPONSE TO PARTICLE OVERLOAD FOR HUMAN RISK ASSESSMENT: A Workshop Consensus Report , 2000, Inhalation toxicology.

[86]  S. Margulies,et al.  Alveolar epithelial surface area-volume relationship in isolated rat lungs. , 1999, Journal of applied physiology.

[87]  Munoz-Aguado,et al.  Sol-Gel Synthesis of Microporous Amorphous Silica from Purely Inorganic Precursors , 1997, Journal of colloid and interface science.

[88]  A. Hartwig,et al.  Sensitive analysis of oxidative DNA damage in mammalian cells: use of the bacterial Fpg protein in combination with alkaline unwinding. , 1996, Toxicology letters.

[89]  B. Lehnert,et al.  Correlation Between Particle Size, in Vivo Particle Persistence, and Lung Injury , 1994 .

[90]  D. Warheit,et al.  Development of a short-term inhalation bioassay to assess pulmonary toxicity of inhaled particles: comparisons of pulmonary responses to carbonyl iron and silica. , 1991, Toxicology and applied pharmacology.

[91]  E. Thompson,et al.  A micro-method for measuring total protein in cerebrospinal fluid by using benzethonium chloride in microtiter plate wells. , 1989, Clinical chemistry.

[92]  F Romagna,et al.  The automated bone marrow micronucleus test. , 1989, Mutation research.

[93]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[94]  J. Heddle,et al.  Towards an improved micronucleus test: studies on 3 model agents, mitomycin C, cyclophosphamide and dimethylbenzanthracene. , 1980, Mutation research.

[95]  O. Nishikaze,et al.  New micro-turbidimetric method for determination of protein in cerebrospinal fluid and urine. , 1979, Clinical chemistry.

[96]  W Schmid,et al.  The micronucleus test. , 1975, Mutation research.

[97]  Wendel Wohlleben,et al.  Nanospecific Guidance in REACH: A Comparative Physical-Chemical Characterization of 15 Materials with Methodical Correlations , 2013 .

[98]  Steffen Foss Hansen,et al.  Specific Advice on Fulfilling Information Requirements for Nanomaterials under REACH (RIP-oN 2) – Final Project Report , 2011 .

[99]  Steffen Foss Hansen,et al.  Specific Advice on Exposure Assessment and Hazard/Risk Characterisation for Nanomaterials under REACH (RIP-oN 3) - Final Project Report , 2011 .

[100]  Steffen Foss Hansen,et al.  Survey on basic knowledge about exposure and potential environmental and health risks for selected nanomaterials , 2011 .

[101]  Peter Wick,et al.  The automated FADU-assay, a potential high-throughput in vitro method for early screening of DNA breakage. , 2011, ALTEX.

[102]  P. M. Williams,et al.  Confounding experimental considerations in nanogenotoxicology. , 2009, Mutagenesis.

[103]  S. Doak,et al.  NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. , 2009, Biomaterials.

[104]  Robert Landsiedel,et al.  Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. , 2009, Inhalation toxicology.

[105]  Martin M. Schumacher,et al.  Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations. , 2004, Mutagenesis.

[106]  R. Tice,et al.  Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing , 2000, Environmental and molecular mutagenesis.

[107]  D. Warheit,et al.  Pulmonary Toxicity Assessments Of Inhaled Ethylene Oxide/Propylene Oxide Copolymer Lubricants In Rats , 1995 .

[108]  M. Salamone.  Toward an improved micronucleus test. Studies on 3 model agents, mitomycin C, CPA and dimethylbenzan-thracene , 1980 .